Arterial stiffness and plasma creatinine in untreated hypertensive patients

Philippe Gosse1, Michel E Safar

  • 1Hypertension Unit, Hospital Saint André, 1 rue Jean Burguet, 33075 Bordeaux, France. philippe.gosse@chu-bordeaux.fr

Insights

In hypertensive patients with healthy kidneys, arterial stiffness is linked to higher plasma creatinine levels. This association is independent of age and 24-hour blood pressure, suggesting an early vascular disease connection.

Area of Science:

  • Cardiovascular Medicine
  • Nephrology
  • Hypertension Research

Background:

  • Increased arterial stiffness is common in hypertension, often linked to renal failure.
  • This stiffness is independent of age, blood pressure, and atherosclerosis, but not diabetes.
  • Previous studies noted a link between reduced creatinine clearance and arterial stiffness in mild renal failure.

Purpose of the Study:

  • To investigate the relationship between arterial stiffness and renal function in newly diagnosed hypertensive patients with preserved kidney function.
  • To determine if this relationship is independent of 24-hour blood pressure (BP).

Main Methods:

  • 263 untreated hypertensive subjects with plasma creatinine <135 micromol/L were studied.
  • 24-hour ambulatory blood pressure and arterial stiffness were measured using a validated device.
  • The cohort was divided into two age groups: <48 years and >=48 years.

Main Results:

  • A significant positive correlation was found between arterial stiffness and plasma creatinine.
  • This correlation remained significant and independent of age, height, gender, traditional risk factors, and 24-hour BP.
  • The association was consistent across both younger and older age groups.

Conclusions:

  • Arterial stiffness and plasma creatinine are positively related in untreated hypertensive individuals with preserved renal function.
  • This relationship is independent of age and ambulatory blood pressure.
  • The findings suggest an independent link between arterial stiffness and renal function at an early stage of hypertensive vascular disease.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance01:25

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance (Clcr), a...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...